ArticleEuropean journal of psychotraumatology2020
Maintenance of treatment gains up to 12-months following a three-week cognitive processing therapy-based intensive PTSD treatment programme for veterans.
Article in European journal of psychotraumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 39 citations in OpenAlex.
- 12-month follow-up of intensive outpatient treatment for PTSD combining prolonged exposure therapy, EMDR and physical activity.BMC psychiatry · 2024Trial
- MassedPsychological medicine · 2023Trial
- Treating posttraumatic stress disorder at home in a single week using 1-week virtual massed cognitive processing therapy.Journal of traumatic stress · 2022Trial
- Therapeutic intensification in post-traumatic stress disorder worldwide: where do we stand?European journal of psychotraumatology · 2026Review
- Effectiveness of massed cognitive processing therapy for posttraumatic stress disorder: A retrospective analysis.Journal of traumatic stress · 2026Article
- Understanding Veterans' Perceived Improvement in PTSD Treatment: Examining its Association with Clinical Predictors and Clinically Meaningful Improvement Thresholds.Cognitive therapy and research · 2025Article
- Brain derived neurotrophic factor and treatment outcomes among veterans attending an intensive treatment program for posttraumatic stress disorder.Journal of psychiatric research · 2024Article
- Veterans' 12-month PTSD and depression outcomes following 2- and 3-week intensive cognitive processing therapy-based treatment.European journal of psychotraumatology · 2024Article
- Examining trauma cognition change trajectories among initial PTSD treatment non-optimal responders: a potential avenue to guide subsequent treatment selection.European journal of psychotraumatology · 2023Article
- More is not always better: 2 weeks of intensive cognitive processing therapy-based treatment are noninferior to 3 weeks.Psychological trauma : theory, research, practice and policy · 2023Article
- Evaluating changes in negative posttrauma cognition as a mechanism of PTSD severity changes in two separate intensive treatment programs for veterans.BMC psychiatry · 2022Article
- Building strong therapeutic relationships quickly: The effect of the perceived working alliance on veterans' intensive PTSD treatment outcomes.Psychotherapy (Chicago, Ill.) · 2022Article
- Abnormal intestinal milieu in posttraumatic stress disorder is not impacted by treatment that improves symptoms.American journal of physiology. Gastrointestinal and liver physiology · 2022Article
- A case series examining PTSD and depression symptom reductions over the course of a 2-week virtual intensive PTSD treatment program for veterans.Psychological trauma : theory, research, practice and policy · 2022Article
- Impact of intensive treatment programs for posttraumatic stress disorder on suicidal ideation in veterans and service members.Psychological services · 2021Article
- Treatment response trajectories in a three-week CPT-Based intensive treatment for veterans with PTSD.Journal of psychiatric research · 2021Article
- Impact of hazardous alcohol use on intensive PTSD treatment outcomes among veterans.European journal of psychotraumatology · 2021Article
- Do morally injurious experiences and index events negatively impact intensive PTSD treatment outcomes among combat veterans?European journal of psychotraumatology · 2021Article
- Feasibility of a 3-week intensive treatment program for service members and veterans with PTSD.Psychological trauma : theory, research, practice and policy · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundIntensive treatment programmes (ITPs) have shown promise for reducing PTSD and depression symptoms. It is still unknown whether treatment gains are maintained following completion.
objectiveThis study examined whether veterans were able to maintain treatment gains for up to 12 months after an ITP for PTSD and whether reductions in negative posttrauma cognitions predicted treatment gain maintenance.
methods209 veterans (62.7% male, mean age = 40.86 years) completed a 3-week, CPT-based ITP for PTSD. Participants' PTSD (PCL-5) and depression (PHQ-9) symptoms were assessed at pre-treatment, post-treatment, and at 3-, 6-, and 12-month follow-up timepoints.
resultsDespite small symptom increases from post-treatment to 3-month follow-up, significant and clinically meaningful reductions in PTSD and depression symptoms were reported from intake to 12 months follow-up (averaging >18 points on the PCL-5 and >6 points on the PHQ-9;
conclusionsOverall maintenance of treatment gains long-term suggests veterans may be able to apply skills acquired during the ITP following treatment. These findings further support the feasibility and effectiveness of intensive, trauma-focused, evidence-based therapy delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.